Optimizing T2D Outcomes: A Person-Centred Evolution in Diabetes Care

Diabetes

Congress industry session

GLP-1 RA

Insulin

Icodec

Semaglutide

Semaglutide (oral)

PHASE 2 (RCT)

PHASE 3 (RCT)

RWE HEOR